SMITH SANDFORD D has filed 7 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 148 shares of CYTOKINETICS INC ($CYTK) on January 02, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2024 | CYTOKINETICS INC | $CYTK | SMITH SANDFORD D | Director | A | Common Stock | 148 | $84.12 | 18,801.0000 | 0 | 0.79% | 0.00% |
| Oct. 2, 2023 | CYTOKINETICS INC | $CYTK | SMITH SANDFORD D | Director | A | Common Stock | 448 | $27.88 | 18,653.0000 | 0 | 2.46% | 0.00% |
| July 3, 2023 | CYTOKINETICS INC | $CYTK | SMITH SANDFORD D | Director | A | Common Stock | 374 | $33.36 | 18,205.0000 | 0 | 2.10% | 0.00% |
| May 10, 2023 | CYTOKINETICS INC | $CYTK | SMITH SANDFORD D | Director | A | Common Stock | 5000 | $0.00 | 17,831.0000 | 0 | 38.97% | 0.00% |
| May 10, 2023 | CYTOKINETICS INC | $CYTK | SMITH SANDFORD D | Director | A | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| April 3, 2023 | CYTOKINETICS INC | $CYTK | SMITH SANDFORD D | Director | A | Common Stock | 298 | $37.71 | 12,831.0000 | 0 | 2.38% | 0.00% |
| Jan. 3, 2023 | CYTOKINETICS INC | $CYTK | SMITH SANDFORD D | Director | A | Common Stock | 253 | $44.35 | 12,533.0000 | 0 | 2.06% | 0.00% |